Recombinant interferon-alfa therapy in children with chronic hepatitis B and cured cancer

Indian Journal of Gastroenterology

Volumn 19, Issue 4, 2000, Pages 197-198

  Kocak, N ^a   Ozen, H ^a   Saltik, I N ^a   Yuce, A ^a   Gurakan, F ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; RECOMBINANT ALPHA2B INTERFERON; VIRUS DNA;

ADOLESCENT; ANTIBODY TITER; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CHRONIC HEPATITIS; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LETTER; LYMPHATIC LEUKEMIA; LYMPHOMA; MALE; NEUROBLASTOMA;

ADOLESCENT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B, CHRONIC; HUMAN; INTERFERON TYPE I, RECOMBINANT; MALE; NEOPLASMS; TREATMENT OUTCOME;

EID: 0033791095     PISSN: 02548860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)

1. Infection with hepatitis A, B, delta, and human immunodeficiency viruses in children receiving cycled cancer chemotherapy
2. Hepatitis B and C virus infections in Turkish children with cancer
3. Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders
4. Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection
5. Characteristics and outcome of acute infection with hepatitis B virus in children with cancer
6. Alpha-interferon-2b treatment for chronic hepatitis-B infection in children with cancer
7. Interferon alfa in treatment of chronic hepatitis B in children with leukemias and lymphomas
8. Retreatment with higher-dose interferon alpha in children with chronic hepatitis B infection